Home » Stocks » QTRX

Quanterix Corporation (QTRX)

Stock Price: $77.10 USD -5.56 (-6.73%)
Updated Mar 2, 2021 4:00 PM EST - Market closed
After-hours: $82.00 +4.90 (6.36%) Mar 2, 4:23 PM
Market Cap 2.45B
Revenue (ttm) 76.16M
Net Income (ttm) -32.67M
Shares Out 30.14M
EPS (ttm) -1.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 2
Last Price $77.10
Previous Close $82.66
Change ($) -5.56
Change (%) -6.73%
Day's Open 83.65
Day's Range 75.69 - 83.75
Day's Volume 406,520
52-Week Range 10.89 - 92.57

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 5 days ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chief...

Business Wire - 1 week ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will releas...

Business Wire - 1 week ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chie...

Business Wire - 2 weeks ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into...

Business Wire - 3 weeks ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its ...

Business Wire - 3 weeks ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the pricing of its ...

Business Wire - 3 weeks ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it has commenc...

Business Wire - 1 month ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman, Chief Exe...

Business Wire - 1 month ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today provided operational and prel...

Market Watch - 1 month ago

Shares of Quanterix Corp. rallied nearly 10% in the extended session Monday after the life-sciences company said the Food and Drug Administration has issued an emergency use authorization for ...

Business Wire - 1 month ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Dr...

Business Wire - 1 month ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Chairman, ...

Business Wire - 2 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and D...

Business Wire - 3 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Appoints William Geist as Chief Operating Officer

Business Wire - 3 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman, Chief Exe...

Seeking Alpha - 3 months ago

Quanterix Corporation's (QTRX) CEO Kevin Hrusovsky on Q3 2020 Results - Earnings Call Transcript

Business Wire - 4 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Chairman, ...

Seeking Alpha - 4 months ago

Quanterix: Still Bullish But Valuation Less Compelling

Business Wire - 4 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into...

Other stocks mentioned: ABT
Seeking Alpha - 5 months ago

Quanterix's industry leading platform, which is highly levered to the growth in precision medicine, can detect protein biomarkers at significantly lower concentrations and at higher sensitivit...

Business Wire - 6 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its ...

Seeking Alpha - 6 months ago

Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q2 2020 Results - Earnings Call Transcript

Seeking Alpha - 9 months ago

Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Quanterix (QTRX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Seeking Alpha - 11 months ago

Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Quanterix Corp (QTRX) CEO Kevin Hrusovsky on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

Other stocks mentioned: CGC, MDT
Seeking Alpha - 1 year ago

Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2019 Results - Earnings Call Transcript

About QTRX

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa p... [Read more...]

Industry
Medical Devices
IPO Date
Dec 7, 2017
CEO
E. Kevin Hrusovsky
Employees
248
Stock Exchange
NASDAQ
Ticker Symbol
QTRX
Full Company Profile

Financial Performance

In 2019, Quanterix's revenue was $56.73 million, an increase of 50.76% compared to the previous year's $37.63 million. Losses were -$40.80 million, 29.4% more than in 2018.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Quanterix stock is "Strong Buy." The 12-month stock price forecast is 72.00, which is a decrease of -6.61% from the latest price.

Price Target
$72.00
(-6.61% downside)
Analyst Consensus: Strong Buy